The Research Group is working on disruptive technologies for the production of advanced biopharmaceuticals and the sustainability of bioprocesses. We work on new process options for production and purification of novel biopharmaceuticals and use 3D printing for fast prototyping of novel unit operations. We combine these novel developments with process modelling on economics and ecological impact to achieve sustainable circular bioprocessing.
We are working on
- Upstream development for advanced medicines (complex biomolecules and bionanoparticles)
- Infection, Transfection and Transduction processes
- Continuous manufacturing
- 3D printing as disruptive technology in Upstream and Downstream processing
- Economic and ecological process modelling
- Circular bioprocessing
The research is based on an integrated process view to achieve sustainable circular bioprocessing. Diverse aspects of scale down models, modelling, material optimization, water and energy reduction, biodegradable bioreactors and compostable bioprocesses are all needed to achieve the European green deal goals of 50% reduction in greenhouse gas emissions by 2030, and climate neutrality by 2050. We find solutions to achieve these goals with partners from academia and industry making bioprocessing fit for the future.
